BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

May 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-04-30

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-30	Common Stock	A	339	$62.586	Acquired	298552	Direct
2020-05-01	Common Stock	M	4000	$21.51	Acquired	302552	Direct
2020-05-01	Common Stock	S	4000	$89.38	Disposed	298552	Direct
2020-05-04	Common Stock	M	5000	$21.51	Acquired	303552	Direct
2020-05-04	Common Stock	S	5000	$88.00	Disposed	298552	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-01	Stock Option (Right to buy Common Stock)	$21.51	M	4000	Disposed	2020-05-11	Common Stock (4000)	Direct
2020-05-04	Stock Option (Right to buy Common Stock)	$21.51	M	5000	Disposed	2020-05-11	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247958	Indirect

Footnotes

F1: Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.

F2: Trade made pursuant to a 10b5-1 plan executed on March 5, 2020.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.